Arimidex Meds for Breast Cancer Pictures

Links shared publicly online about this topic

Medical News: SABCS: Mixed Picture for Neoadjuvant Breast CA Tx - in Meeting Coverage, SABCS from MedPage Today

medpagetoday.com — “SAN ANTONIO -- Neoadjuvant trials reported here at the San Antonio Breast Cancer Symposium gave two thumbs up to anti-HER2 combos but flunked bevacizumab (Avastin), as a leading oncologist explains inView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 13, 2010 at 4:09 pm By:

MedicalNews Medical News Health News

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video) http://bit.ly/evxZwR

1 year ago...

Medical News: SABCS: Mixed Picture for Neoadjuvant Breast CA Tx - in Meeting Coverage, SABCS from MedPage Today

medpagetoday.com — “SAN ANTONIO -- Neoadjuvant trials reported here at the San Antonio Breast Cancer Symposium gave two thumbs up to anti-HER2 combos but flunked bevacizumab (Avastin), as a leading oncologist explains inView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 13, 2010 at 4:53 pm By:

FightCancer FightCancer Health News

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video) http://bit.ly/gqkI3U

1 year ago...

Effect of soy isoflavones on breast cancer recurre... [CMAJ. 2010] - PubMed result

ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.View full resource at ncbi.nlm.nih.gov

  • View Related
  • Share

Most Recently Shared on March 19, 2011 at 12:19 pm By:

SamanthaHeller Samantha Heller, RD Nutritionist and Dietitian

Study:#soy associated w/ lower risk of #breastcancer recurrence in women w/ estrogen/progesterone+ tumors & Arimidex http://1.usa.gov/eYN1v5

1 year ago...

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video) - QualityPoint Technologies

qualitypointtech.net — “SAN ANTONIO (MedPage Today) -- Neoadjuvant trials reported here at the San Antonio Breast Cancer Symposium gave two thumbs up to anti-HER2 combos but flunked bevacizumab (Avastin), as a leading oncologist explains in this exclusive InFocus report.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on December 13, 2010 at 5:03 pm By:

MedicalFeed MedicalFeed Health News Feed

SABCS: Mixed Picture for Neoadjuvant Breast CA Tx (with video): SAN ANTONIO (MedPage Today) -- Neoadjuvant trials ... http://bit.ly/hIGoBT

1 year ago...

Medical News: SABCS: Vitamin D Reduces Aromatase Inhibitor Pain - in Meeting Coverage, SABCS from MedPage Today

medpagetoday.com — “SAN ANTONIO -- High-dose vitamin D significantly reduced mucle and joint pain in breast cancer patients treated with the aromatase inhibitor anastrozole (Arimidex), results of a small, randomized clinView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 15, 2009 at 5:26 pm By:

MarcusPainMD Norman Marcus, M.D. Doctor, Pain Medicine Physician, and Physician

Breast cancer? Muscle pain? It could be related to Vitamin D deficiency http://bit.ly/8JxUqm

2 years ago...

Walk 40 Miles in My Shoes --" Cancer Matters

cancer-matters.blogs.hopkinsmedicine.org — “Walk 40 Miles in My Shoes --" Cancer MattersView full resource at cancer-matters.blogs.hopkinsmedicine.org

  • View Related
  • Share

Most Recently Shared on April 30, 2011 at 3:54 pm By:

HopkinsMedNews JohnsHopkinsMedicine Health News

Pictures: Blogger and breast cancer survivor Elissa Bantug at the Avon Walk in Wash, D.C. http://bit.ly/lHUSQ3

1 year ago...

Medical News: ASCO Breast: Ten Years On, Anastrazole Still Tops SERM - in Meeting Coverage, ASCO Breast from MedPage Today

medpagetoday.com — “NATIONAL HARBOR, Md. -- The aromatase inhibitor anastrozole (Arimidex) extended its disease control advantage over tamoxifen in an analysis of 10-year outcomes in a large randomized clinical trial inView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 4, 2010 at 12:20 am By:

FightCancer FightCancer Health News

ASCO Breast: Ten Years On, Anastrazole Still Tops SERM http://bit.ly/cJynSK

2 years ago...

Chaparral | GreenMedInfo | Substance | Natural Medicine | Alternative Medicine

greenmedinfo.com — “GreenMedInfo contains 4 articles on Chaparral indicating that it may have therapeutic value in the treatment of Oxidative Stress, Breast Cancer, and GallstonesView full resource at greenmedinfo.com

  • View Related
  • Share

Most Recently Shared on May 4, 2011 at 11:56 am By:

sayerji Sayer Ji CAM and Health Advocate

The oldest known living organism on the planet is found in this picture. "The creosote bush, in Southern... http://fb.me/FiDDfgRi

1 year ago...

ASCO Breast: Ten Years On, Anastrazole Still Tops SERM - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- NATIONAL HARBOR, Md. -- The aromatase inhibitor anastrozole (Arimidex) extended its disease control advantage over tamoxifen in an analysis of 10-year outcomes in a large randomized clinical trial in breast cancer.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on October 3, 2010 at 11:36 pm By:

MedicalFeed MedicalFeed Health News Feed

ASCO Breast: Ten Years On, Anastrazole Still Tops SERM: (MedPage Today) -- NATIONAL HARBOR, Md. -- The aromatase i... http://bit.ly/cxT853

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390